Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamics study of multiple rising oral doses of BI 14332 CL in adults with Type 2 diabetes; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BI 14332 CL

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: TERMINATED